This is a routine post-vesting sale by an officer, no material signal. Monitor for any subsequent Form 4 filings to confirm execution, but this alone does not warrant a trading response.
Price Chart
Executive Summary
Todd Anderman, an Officer of Ocular Therapeutix, filed a Form 144 notice of intent to sell 11,984 shares of common stock, with an estimated aggregate market value of $87,315.42 based on a filing date of October 8, 2026. The shares were acquired via restricted stock vesting under a registered plan on October 7, 2026, and the sale is planned through Morgan Stanley. This is a routine insider sale tied to equity compensation vesting, not a discretionary open-market sale, and the dollar amount is modest relative to the issuer's market cap.
Key Facts
- Insider Todd Anderman (Officer) filed Form 144 on 2026-10-08 to sell 11,984 shares.
- Estimated aggregate market value of proposed sale: $87,315.42.
- Shares were acquired on 2026-10-07 via restricted stock vesting under a registered plan.
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services.
- The filing is an advance notice of intent to sell; the actual sale may not occur.
Financial Impact
Proposed sale of $87,315 in value, representing a small fraction of the insider's likely holdings and a negligible percentage of Ocular Therapeutix's market cap.
Risk Factors
- The sale is not yet executed; the insider may choose not to sell.
- No additional context on the insider's total holdings or the company's current financial position is provided in the filing.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010123 |
| Document: 0001950047-26-010123-index.html | 0001950047-26-010123 |
| Document: 0001950047-26-010123.txt | 0001950047-26-010123 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 12d ago | 8-K | $6.29 | awaiting T+60 | awaiting T+60 | $7.48 (+18.92%) |
Oct 8, 2026 20d ago | 144 | $7.54 | awaiting T+60 | awaiting T+60 | $7.48 (−0.80%) |
Sep 2, 2026 8w ago | Insider Cluster | $10.64 | awaiting T+60 | awaiting T+60 | $7.48 (−29.70%) |
Aug 26, 2026 9w ago | Insider Cluster | $10.82 | awaiting T+60 | awaiting T+60 | $7.48 (−30.87%) |
Aug 3, 2026 12w ago | 8-K | $8.40 $6.61 | ▼ −21.31% | ▼ −23.09% | $7.48 (−10.95%) |
Jun 17, 2026 19w ago | Press Release | $9.64 $10.49 | ▲ +8.82% | ▲ +5.67% | $7.48 (−22.41%) |
Jun 12, 2026 19w ago | 8-K | $8.99 $11.47 | ▲ +27.59% | ▲ +26.58% | $7.48 (−16.80%) |
Jun 4, 2026 21w ago | Press Release | $8.80 $10.36 | ▲ +17.73% | ▲ +15.85% | $7.48 (−15.00%) |
May 28, 2026 21w ago | Insider Cluster | $9.01 $10.78 | ▲ +19.64% | ▲ +18.46% | $7.48 (−16.98%) |
May 5, 2026 25w ago | 8-K | No price | awaiting T+60 | awaiting T+60 | No price |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers